Results of activity of Chimfarm OJSC (Kazakhstan) for the 9 months of 2003

/IRBIS, October 28, 03/ - Chimfarm OJSC (Shymkent), whose shares are circulating in Kazakhstan stock exchange's (KASE) official "B" listing category, provided KASE with the financial statement for the 9 months of 2003. The following indicators are result of the issuer's financial and economic activity for the 9 months of 2003, based upon the issuer's data (in th. KZT, unless otherwise specified): --------------------------------------------------------- As of As of Indicator Oct 1, 02 Oct 1, 03 Change,% ---------------------------- --------- --------- -------- Authorized capital (paid) 1,557,675 1,557,675 0.0 Shareholders' equity 1,664,523 1,887,141 +13.4 Total assets 3,514,447 4,215,236 +19.9 Net working capital 78,532 1,239,861 +1,478.8 Accounts receivable 344,715 535,553 +55.4 Total liabilities 1,849,924 2,328,095 +25.8 Attracted credits 777,171 1,806,613 +132.5 Accounts payable 1,072,753 521,482 -51.4 Sales volume 1,015,824 1,469,634 +44.7 Cost of goods sold 655,866 1,102,547 +68.1 Net income for the period 29,836 30,167 +1.1 Book value of one share, KZT 317.37 359.82 +13.4 --------------------------------------------------------- Relative to similar period of 2002 there increase of: - shareholders' equity - by KZT222.6 m. as the result of increase of additional unpaid capital by 195.6 m., and total sum of undistributed income by 27.0 m.; - assets - by KZT700.8 m., including: long-term investments - by 471.1 m., accounts receivable - by 190.8 m, expenses of future periods - by 190.6 m., inventory - by 200.1 m. and other assets - by 15.6 m., whereas there took place decrease of residual value of fixed assets by 367.4 m.; - liabilities - by KZT478.2 m., that was caused by increase of attracted credits volume (long-term) by KZT1.0 bn., whereas there took place decrease of accounts payable by 551.3 m.; - sales volume - by KZT453.8 m.; - cost of goods sold - by KZT446.7 m. Net income, which Chimfarm OJSC earned during the first 9 months of 2003, increased by KZT331.0 th. in comparison with corresponding period of 2002. Company's primary activities - production of drugs; quality control and conducting of certification tests of drugs, ethyl alcohol and distillery production by the laboratory, which has passed accreditation; sale of chemical-pharmaceutical preparations, medical, sanitary-hygienic means and medical makings; preparation, purchasing of medical raw stuff; production and sale of other goods. [2003-10-28]